Optimizing omalizumab dosing in severe asthma-the exploration of therapeutic drug monitoring

J Allergy Clin Immunol Pract. 2021 Mar;9(3):1408-1410.e1. doi: 10.1016/j.jaip.2020.12.013. Epub 2020 Dec 15.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Asthmatic Agents* / therapeutic use
  • Asthma* / drug therapy
  • Drug Monitoring
  • Humans
  • Omalizumab / therapeutic use
  • Treatment Outcome

Substances

  • Anti-Asthmatic Agents
  • Omalizumab